Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome

To investigate the effects of saffron as an adjunct treatment for people with schizophrenia who have antipsychotic-induced metabolic syndrome.

This is a protocol.

Health topics:

Mental health > Schizophrenia & psychosis > Complementary & alternative therapy

Published:

9 March 2018

Authors:

Zare M, Bazrafshan A, Malekpour Afshar R, Mazloomi S

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Zare M, Bazrafshan A, Malekpour Afshar R, Mazloomi S. Saffron (adjunct) for people with schizophrenia who have antipsychotic-induced metabolic syndrome. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012950. DOI: 10.1002/14651858.CD012950